Usefulness of laboratory parameters and chest CT in the early diagnosis of COVID-19.


Journal

Revista do Instituto de Medicina Tropical de Sao Paulo
ISSN: 1678-9946
Titre abrégé: Rev Inst Med Trop Sao Paulo
Pays: Brazil
ID NLM: 7507484

Informations de publication

Date de publication:
2022
Historique:
received: 30 10 2021
accepted: 07 02 2022
entrez: 6 4 2022
pubmed: 7 4 2022
medline: 9 4 2022
Statut: epublish

Résumé

In the present study, the importance of laboratory parameters and CT findings in the early diagnosis of COVID-19 was investigated. To this end, 245 patients admitted between April 1st, and May 30th, 2020 with suspected COVID-19 were enrolled. The patients were divided into three groups according to chest CT findings and RT-PCR results. The non-COVID-19 group consisted of 71 patients with negative RT-PCR results and no chest CT findings. Ninety-five patients with positive RT-PCR results and negativechest CT findings were included in the COVID-19 group; 79 patients with positive RT-PCR results and chest CT findings consistent with COVID-19 manifestations were included in COVID-19 pneumonia group. Chest CT findings were positive in 45% of all COVID-19 patients. Patients with positive chest CT findings had mild (n=30), moderate (n=21) andor severe (n=28) lung involvement. In the COVID-19 group, CRP levels and the percentage of monocytes increased significantly. As disease progressed from mild to severe, CRP, LDH and ferritin levels gradually increased. In the ROC analysis, the area under the curve corresponding to the percentage value of monocytes (AUC=0.887) had a very good accuracy in predicting COVID-19 cases. The multinomial logistic regression analysis showed that CRP, LYM and % MONO were independent factors for COVID-19. Furthermore, the chest CT evaluation is a relevant tool in patients with clinical suspicion of COVID-19 pneumonia and negative RT-PCR results. In addition to decreased lymphocyte count, the increased percentage of monocytes may also guide the diagnosis.

Identifiants

pubmed: 35384959
pii: S0036-46652022000100213
doi: 10.1590/S1678-9946202264028
pmc: PMC8993152
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e28

Références

J Clin Lab Anal. 2020 Oct;34(10):e23475
pubmed: 32681559
Eur Radiol. 2020 Sep;30(9):4874-4882
pubmed: 32296940
J Clin Lab Anal. 2020 Oct;34(10):e23562
pubmed: 32893398
Diagn Microbiol Infect Dis. 2021 Feb;99(2):115169
pubmed: 33202303
Int Immunopharmacol. 2021 Dec;101(Pt A):108144
pubmed: 34607235
Ann Intern Med. 2020 Jul 21;173(2):147-148
pubmed: 32267912
Eur J Nucl Med Mol Imaging. 2020 Aug;47(9):2083-2089
pubmed: 32399620
AJR Am J Roentgenol. 2020 Oct;215(4):834-838
pubmed: 32412790
Clin Chim Acta. 2020 Nov;510:475-482
pubmed: 32798514
Acta Biomed. 2020 Sep 07;91(3):e2020003
pubmed: 32921701
Eur Radiol. 2020 Dec;30(12):6808-6817
pubmed: 32623505
J Bras Pneumol. 2020 Apr 09;46(2):e20200121
pubmed: 32294718
Radiology. 2020 Aug;296(2):E32-E40
pubmed: 32101510
Med Clin (Engl Ed). 2020 Aug 28;155(4):143-151
pubmed: 32864456
Acta Clin Belg. 2022 Apr;77(2):261-267
pubmed: 32935644
Clin Chem Lab Med. 2020 Jun 25;58(7):1095-1099
pubmed: 32301746
Int J Hematol. 2020 Oct;112(4):553-559
pubmed: 32656638
Int J Lab Hematol. 2020 Dec;42(6):e266-e269
pubmed: 32981233
J Med Virol. 2020 Jul;92(7):856-862
pubmed: 32281668
Arch Acad Emerg Med. 2020 Apr 04;8(1):e43
pubmed: 32259132
Lancet Infect Dis. 2020 Apr;20(4):425-434
pubmed: 32105637
Diagn Interv Radiol. 2020 Jul;26(4):308-314
pubmed: 32558645
J Med Virol. 2021 Feb;93(2):1029-1037
pubmed: 32749709
Biomark Med. 2020 Sep;14(13):1207-1215
pubmed: 32692248
Int J Infect Dis. 2020 Jul;96:467-474
pubmed: 32425643
Tohoku J Exp Med. 2020;252(2):109-119
pubmed: 33028754
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
Biochem Med (Zagreb). 2020 Oct 15;30(3):030503
pubmed: 32774121
Clin Med (Lond). 2020 Jul;20(4):e114-e119
pubmed: 32620590
Int Immunopharmacol. 2021 Feb;91:107285
pubmed: 33348293

Auteurs

Ayfer Colak (A)

University of Health Sciences, Tepecik Training and Research Hospital, Department of Medical Biochemistry, Izmir, Turkey.

Dilek Oncel (D)

University of Health Sciences, Tepecik Training and Research Hospital, Department of Radiology, Izmir, Turkey.

Zeynep Altın (Z)

University of Health Sciences, Tepecik Training and Research Hospital, Department of Internal Medicine, Izmir, Turkey.

Melda Turken (M)

University of Health Sciences, Tepecik Training and Research Hospital, Department of Infectious Diseases and Clinical Microbiology, Izmir, Turkey.

Fatma Demet Arslan (FD)

University of Health Sciences, Tepecik Training and Research Hospital, Department of Medical Biochemistry, Izmir, Turkey.

Veli Iyilikci (V)

University of Health Sciences, Tepecik Training and Research Hospital, Department of Medical Biochemistry, Izmir, Turkey.

Nisel Yilmaz (N)

University of Health Sciences, Tepecik Training and Research Hospital, Department of Medical Microbiology, Izmir, Turkey.

Guray Oncel (G)

Bakircay University, Cigli Training and Research Hospital, Department of Radiology, Izmir, Turkey.

Sukran Kose (S)

University of Health Sciences, Tepecik Training and Research Hospital, Department of Infectious Diseases and Clinical Microbiology, Izmir, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH